CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced that its subsidiary, Invitrogen Federal Systems, under a $3.9 million contract from the Defense Threat Reduction Agency (DTRA), successfully completed the development of a prototype hand-held device for the detection of multiple biothreat agents in a single sample.
